Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

A First-in-Human (FIH) Phase 1 Study of the Anti-LILRB4 Antibody IO-202 in Relapsed/Refractory (R/R) Myelomonocytic and Monocytic Acute Myeloid Leukemia (AML) and R/R Chronic Myelomonocytic Leukemia (CMML)

Courtney D. DiNardo, MD MSCE, Daniel A. Pollyea, Marina Konopleva, MD PhD, Kyu Hong, MS, Tao Huang, PhD, An Song, PhD, Elizabeth Wieland, MS, Paul Woodard, MD, Charlene Liao, PhD, Chengcheng Zhang, PhD, Prapti A. Patel, MD, Ahmed Aribi, MD

Blood (2020) 136 (Supplement 1): 19–20.

https://doi.org/10.1182/blood-2020-137665

Published: 2020

Journal Articles

Comparative Analysis of Alpha-Beta T-Cell and B-Cell Depleted (abTCD) HLA-Haploidentical Hematopoietic Stem Cell Transplantation (haplo-HSCT) Versus Abtcd Haplo-HSCT with T-Cell Add-Back of Rivogenlecleucel Cell [Donor T Cells Transduced with the Inducible Caspase 9 (iC9) Gene Safety Switch] in Children with High-Risk Acute Leukemia (AL) in Remission

Annalisa Ruggeri, MD, Pietro Merli, MD, Mattia Algeri, MD, Marco Zecca, Franca Fagioli, MD, Giuseppina Li Pira, PhD, Valentina Bertaina, PhD, Arcangelo Prete, MD, Mauro Montanari, MD, Francesca Del Bufalo, MD, Luciana Vinti, MD, Daria Pagliara, MD PhD, Melissa Aldinger, PharmD, Kai Chan, Paul Woodard, Federica Galaverna, MD, Franco Locatelli, MD

Blood (2019) 134 (Supplement_1): 145.

https://doi.org/10.1182/blood-2019-125366

Published: 2019

Journal Articles

Safety and Efficacy of Atezolizumab in Combination with Obinutuzumab and Bendamustine in Patients with Previously Untreated Follicular Lymphoma: An Interim Analysis

Anas Younes, MD, Burke M. John, Catherine S Diefenbach, Silvia Ferrari, Cyrus Kahn, Jeffrey P. Sharman, MD, Monica Tani, Chaitra S. Ujjani, MD, Umberto Vitolo, MD, Sam Yuen, Paul Woodard, Kirsten Mundt, Günter Fingerle-Rowson, Surya Chitra, Gila Sellam, Rodica Morariu-Zamfir, Michael Gilbertson

Blood (2017) 130 (Supplement 1): 481.

https://doi.org/10.1182/blood.V130.Suppl_1.481.481

Published: 2017

Journal Articles

Evidence of Targetable Immune Dysfunction in the Bone Marrow of Patients with Intermediate/High-Risk Myelodysplastic Syndrome Refractory to Hypomethylating Agents

Cherie Green, Mark Yan, Stefani Nalle, Connie Ma, Alberto Robert, Judy Zhong, Kartik Krishnan, Patrick Phuong, PharmD, John Byon, Paul Woodard, Michael J. Nemeth, PhD, Elizabeth A. Griffiths, MD, Joanne I. Adamkewicz, Jeffrey M. Venstrom, Monique Dail

Blood (2017) 130 (Supplement 1): 4241.

https://doi.org/10.1182/blood.V130.Suppl_1.4241.4241

Published: 2017

Journal Articles

Safety and Clinical Activity of Atezolizumab (Anti-PDL1) in Combination with Obinutuzumab in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma

Brian G. Till, MD, Steven I. Park, MD, Leslie L. Popplewell, MD, Andre Goy, MD, Elicia Penuel, PhD, Jeffrey M Venstrom, MD, Bo Liu, Guenter Fingerle-Rowson, MD PhD, John Byon, MD PhD, Paul Woodard, MD, M. Lia Palomba, MD

Blood (2015) 126 (23): 5104.

https://doi.org/10.1182/blood.V126.23.5104.5104

Published: 2015

Journal Articles

Integrated Analysis of Long Term Safety in Patients (pts) with Chronic Immune Thrombocytopenia (ITP) Treated with Romiplostim.

Douglas B. Cines, MD, Terry B. Gernsheimer, MD, Jeffrey Wasser, MD, Bertrand Godeau, MD, Andrew Provan, MD, Roger M. Lyons, MD, Ivy Altomare, Xuena Wang, PhD, Paul Woodard, MD

Blood (2012) 120 (21): 2185.

https://doi.org/10.1182/blood.V120.21.2185.2185

Published: 2012

Journal Articles

Hematopoietic Progenitor Cell Transplantation from Parental Donors for Children with Sickle Cell Anemia and Stroke.

Paul Woodard, MD, Gregory Hale, MD, Wing Leung, MD, PhD, Raymond Barfield, MD, PhD, Kimberly Kasow, DO, Renee Madden, MD, Rupert Handgretinger, MD, PhD, John Cunningham, MD, Russell Ware, MD, PhD

Blood (2007) 110 (11): 3393.

https://doi.org/10.1182/blood.V110.11.3393.3393

Published: 2007

Journal Articles

Rapid Immune Reconstitution after a Reduced-Intensity Conditioning Regimen and a CD3-Depleted Haploidentical Stem Cell Graft for Pediatric Refractory Hematologic Malignancies.

Xiaohua Chen, MD, PhD, Gregory A. Hale, MD, Raymond C. Barfield, MD PhD, Ely Benaim, MD, Wing H. Leung, MD PhD, James Knowles, MS, Edwin M. Horwitz, MD PhD, Paul Woodard, MD, Kimberly A. Kasow, MD, Usman Yusuf, MD, Fred G. Behm, MD, Randall T. Hayden, MD, Sheila A. Shurtleff, PhD, Victoria Turner, PhD, Deo Kumar Srivastava, PhD, Rupert Handgretinger, MD PhD

Blood (2006) 108 (11): 5311.

https://doi.org/10.1182/blood.V108.11.5311.5311

Published: 2006

Journal Articles

Reduced-Intensity Conditioning (RIC) in Haploidentical Transplantation.

Ely Benaim, MD, Gregory Hale, MD, Edwin Horwitz, MD, PhD, Wing Leung, MD, PhD, Paul Woodard, MD, Usman Yusuf, MD, Rupert Handgretinger, MD, PhD

Blood (2004) 104 (11): 2147.

https://doi.org/10.1182/blood.V104.11.2147.2147

Published: 2004

Journal Articles

Cidofovir Is Safe and Effective in the Treatment of Adenoviral Infection in Pediatric Hematopoietic Stem Cell Transplantation.

Usman Yusuf, MD, Gregory Hale, MD, Paul Woodard, MD, Ely Benaim, MD, Kimberly Kasow, DO, Edwin Horwitz, MD, Wing Leung, MD, Deo Srivastava, PhD, Rupert Handgretinger, MD, Randy Haden, PhD

Blood (2004) 104 (11): 2232.

https://doi.org/10.1182/blood.V104.11.2232.2232

Published: 2004

Journal Articles

CD133 + Hematopoietic Cells Successfully Reconstitute Hematopoiesis Following Autologous Peripheral Blood Stem Cell Transplantation.

Gregory A. Hale, MD, Edwin Horwitz, MD, Wing Leung, MD, Paul Woodard, MD, Paul Eldridge, PhD, Usman Yusuf, MD, Ely Benaim, MD, Kimberly Kasow, DO, Kumar Srivastava, PhD, Rupert Handgretinger, MD

Blood (2004) 104 (11): 444.

https://doi.org/10.1182/blood.V104.11.444.444

Published: 2004

Journal Articles

Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease

Blood (2003) 101 (6): 2137–2143.

https://doi.org/10.1182/blood-2002-07-2090

Published: 2003

NARROW

A First-in-Human (FIH) Phase 1 Study of the Anti-LILRB4 Antibody IO-202 in Relapsed/Refractory (R/R) Myelomonocytic and Monocytic Acute Myeloid Leukemia (AML) and R/R Chronic Myelomonocytic Leukemia (CMML)

Safety and Efficacy of Atezolizumab in Combination with Obinutuzumab and Bendamustine in Patients with Previously Untreated Follicular Lymphoma: An Interim Analysis

Evidence of Targetable Immune Dysfunction in the Bone Marrow of Patients with Intermediate/High-Risk Myelodysplastic Syndrome Refractory to Hypomethylating Agents

Safety and Clinical Activity of Atezolizumab (Anti-PDL1) in Combination with Obinutuzumab in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma

Integrated Analysis of Long Term Safety in Patients (pts) with Chronic Immune Thrombocytopenia (ITP) Treated with Romiplostim.

Hematopoietic Progenitor Cell Transplantation from Parental Donors for Children with Sickle Cell Anemia and Stroke.

Rapid Immune Reconstitution after a Reduced-Intensity Conditioning Regimen and a CD3-Depleted Haploidentical Stem Cell Graft for Pediatric Refractory Hematologic Malignancies.

Reduced-Intensity Conditioning (RIC) in Haploidentical Transplantation.

Cidofovir Is Safe and Effective in the Treatment of Adenoviral Infection in Pediatric Hematopoietic Stem Cell Transplantation.

CD133 + Hematopoietic Cells Successfully Reconstitute Hematopoiesis Following Autologous Peripheral Blood Stem Cell Transplantation.

Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only